Dec 05, 2017 1:00 PM

VolitionRx Limited to Attend Conferences in December

Nov 10, 2017 1:00 PM

Singapore Volition signs Memorandum of Understanding with the National Taiwan University to Conduct Two Large Clinical Studies

Nov 09, 2017 10:00 PM

VolitionRx Limited Announces Third Quarter 2017 Financial Results and Business Update

Nov 02, 2017 1:00 PM

VolitionRx Limited Schedules Third Quarter 2017 Earnings Conference Call and Business Update

Sep 22, 2017 2:00 PM

VolitionRx Announces the Initial Sale of its New Nu.Q(TM) Research Kits

Sep 21, 2017 10:00 PM

VolitionRx Limited Awarded $1.5 Million in Non-Dilutive Funding

Sep 19, 2017 10:00 PM

VolitionRx Announces its European Colorectal Cancer Strategy

Sep 15, 2017 1:00 PM

VolitionRx to Attend Two Major Conferences in Asia

Sep 14, 2017 2:00 PM

Volition Granted Four Additional Patents

Sep 06, 2017 10:00 PM

VolitionRx Limited to Attend Multiple Conferences in September

Aug 22, 2017 10:00 PM

Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers

Aug 09, 2017 10:00 PM

VolitionRx Limited Announces Second Quarter 2017 Financial Results and Business Update

Aug 03, 2017 10:00 PM

VolitionRx Limited Schedules Second Quarter 2017 Earnings Conference Call and Business Update

Jul 19, 2017 10:00 PM

VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute

Jul 18, 2017 12:00 PM

Volition America, Inc. Announces a Colorectal Cancer Screening Trial containing approximately 13,500 Subjects in Collaboration with the Early Detection Research Network of the U.S. National Cancer Institute

Jun 30, 2017 3:00 PM

Volition to Present at the EuropaColon Advocacy Masterclass and Exhibit at the European Society for Medical Oncology Gastrointestinal Cancer Congress

Jun 27, 2017 1:00 PM

VolitionRx Limited Corrects an Earlier Announcement

May 26, 2017 12:00 PM

VolitionRx Limited to Present at Multiple Investor Conferences in June

May 18, 2017 3:00 PM

A new publication reports that 91% of colorectal cancers were detected at 90% specificity in a completed prospective trial using Volition's Nu.Q(TM) assays

May 11, 2017 12:00 PM

VolitionRx Limited Announces First Quarter 2017 Financial Results and Business Update

May 08, 2017 2:00 PM

VolitionRx Limited Schedules First Quarter 2017 Earnings Conference Call and Business Update

Apr 27, 2017 1:00 PM

Volition makes progress with its Colorectal Cancer Screening Triage Test in both Asia and Europe

Apr 21, 2017 2:00 PM

Volition opens a new Research and Development facility in Belgium with a state of the art, purpose-built laboratory

Apr 11, 2017 1:00 PM

VolitionRx Appoints David Vanston as Chief Financial Officer

Mar 28, 2017 10:00 PM

Volition America, Inc. Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States

Mar 20, 2017 6:30 AM

VolitionRx Limited Announces the Formation of Volition America, Inc.

Mar 14, 2017 1:56 PM

VolitionRx Limited Celebrates CE Mark Announcement By Ringing Closing Bell at the New York Stock Exchange

Mar 13, 2017 6:30 AM

VolitionRx Limited to Ring the New York Stock Exchange Closing Bell on Monday, March 13th at 4 pm Eastern Daylight Time

Mar 10, 2017 6:30 AM

VolitionRx Limited Announces Full Fiscal Year 2016 Financial Results and Business Update

Mar 08, 2017 6:30 AM

VolitionRx Limited to Present at the 29th Annual ROTH Conference

Mar 06, 2017 5:00 PM

VolitionRx Limited Schedules Fourth Quarter and Full Year 2016 Earnings Conference Call and Business Update

Mar 02, 2017 6:30 AM

A Logistics and Pathway Design Study for Volition's CE Marked NuQ(TM) Triage Test has been Commenced in the Capital Region of Denmark

Feb 24, 2017 6:30 AM

VolitionRx Limited's Triage Test Results Validated in Prospective Trial

Feb 23, 2017 9:00 AM

VolitionRx Limited to Attend the BTIG 2017 Medical Technology, Life Sciences, and Diagnostics Conference

Feb 09, 2017 9:26 AM

VolitionRx Limited to Present at Source Capital Group's 2nd Annual Disruptive Growth & Healthcare Conference on February 15, 2017

Jan 05, 2017 6:30 AM

VolitionRx Limited Strengthens Team with Key Appointment to Drive Sales and Trials in Asia

Jan 03, 2017 9:00 AM

Press Releases